May 11, 2017 / 12:47 PM / 2 months ago

BRIEF-Teva interim CEO sees more headcount reductions

1 Min Read

May 11 (Reuters) - Teva Pharmaceutical Industries Ltd

* Interim CEO: headcount reduced by 5,000 since Actavis deal, expects more cuts by end of 2017

* Interim CEO: deteriorating situation in Venezuela could impact ability to produce products there Further company coverage: (Reporting by Tova Cohen)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below